腸疾患検査の世界市場:免疫測定、分子診断

◆英語タイトル:Global Enteric Disease Testing Market 2016-2020
◆商品コード:IRTNTR8514
◆発行会社(調査会社):Technavio
◆発行日:2016年7月20日
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、腸疾患検査の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、腸疾患検査の世界市場規模及び予測、疾患種類別分析、地域別分析/市場規模、市場の成長要因、市場の課題、医療費償還シナリオ、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Enteric Diseases
Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests.

Technavio’s analysts forecast the global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of enteric disease testing products for Bacterial enterics (Clostridium difficile, Campylobacter, enterohemorrhagic Escherichia coli [EHEC], and Helicobacter pylori) and Viral enterics (Norovirus and Rotavirus)

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Enteric Disease Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Alere
• bioMérieux
• Cepheid
• DiaSorin

[Other prominent vendors]
• BD
• Biomerica
• Coris BioConcept
• Meridian Bioscience
• Mobidiag
• Quidel
• Quest Diagnostics
• R-Biopharm
• Trinity Biotech
• Thermo Fisher Scientific

[Market driver]
• Increase in adoption of molecular diagnostic testing
• For a full, detailed list, view our report

[Market challenge]
• Lack of awareness in underdeveloped countries
• For a full, detailed list, view our report

[Market trend]
• Shift from singleplex to multiplex testing
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Reimbursement scenario: An overview

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Types of clinical diagnostic testing
• Immunoassay testing
• Molecular diagnostic testing

PART 08: Market segmentation by disease type
• Bacterial enterics
• Viral enterics

PART 09: Geographical segmentation
• Geographical segmentation of global enteric disease testing market 2015-2020
• Enteric disease testing market in Americas
• Enteric disease testing market in EMEA
• Enteric disease testing market in APAC

PART 10: Market drivers
• High incidence of enteric diseases
• Increase in adoption of molecular diagnostic testing
• Availability of novel enteric testing platforms

PART 11: Impact of drivers

PART 12: Market challenges
• Stringent regulatory environment
• Lack of awareness in underdeveloped countries
• Shortage of skilled technicians

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Development of novel NAAT for enteric disease testing
• Shift from singleplex to multiplex testing

PART 15: Vendor landscape
• Competitive scenario
• Key vendor analysis
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Reimbursement perspectives of healthcare entities
Exhibit 03: Global enteric disease testing market
Exhibit 04: Global enteric disease testing market 2015-2020 ($ millions)
Exhibit 05: Five forces analysis
Exhibit 06: Segmentation of global enteric disease testing market by microorganism 2015
Exhibit 07: Segmentation of global enteric disease testing market by geography 2015
Exhibit 08: Segmentation of global enteric disease testing market by geography 2020
Exhibit 09: Segmentation of global enteric disease testing market by geography 2015-2020
Exhibit 10: Enteric disease testing market in Americas 2015-2020 ($ millions)
Exhibit 11: Enteric disease testing market in EMEA 2015-2020 ($ millions)
Exhibit 12: Enteric disease testing market in APAC 2015-2020 ($ millions)
Exhibit 13: Impact of drivers
Exhibit 14: Impact of drivers and challenges
Exhibit 15: Alere: Key takeaways
Exhibit 16: bioMérieux: Key takeaways
Exhibit 17: Cepheid: Key takeaways
Exhibit 18: DiaSorin: Key takeaways



【掲載企業】

Alere, bioMérieux, Cepheid, DiaSorin, BD, Biomerica, Coris BioConcept, Meridian Bioscience, Mobidiag, Quest Diagnostics, R-Biopharm, Trinity Biotech, Thermo Fisher Scientific.


【レポートのキーワード】

腸疾患検査、消化管疾患検査、免疫測定、分子診断、胃痛、嘔吐、下痢、吐き気、体重減少、食欲不振、熱、治療

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[腸疾患検査の世界市場:免疫測定、分子診断]販売に関する免責事項
★調査レポート[腸疾患検査の世界市場:免疫測定、分子診断]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆